A detailed history of Mather Group, Llc. transactions in Dexcom Inc stock. As of the latest transaction made, Mather Group, Llc. holds 412 shares of DXCM stock, worth $31,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
412
Previous 1,263 67.38%
Holding current value
$31,262
Previous $143,000 81.12%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$64.0 - $116.06 $54,464 - $98,767
-851 Reduced 67.38%
412 $27,000
Q2 2024

Jul 08, 2024

BUY
$110.31 - $140.45 $41,697 - $53,090
378 Added 42.71%
1,263 $143,000
Q1 2024

Apr 08, 2024

BUY
$114.22 - $140.1 $101,084 - $123,988
885 New
885 $122,000
Q1 2022

May 13, 2022

SELL
$94.08 - $130.2 $50,238 - $69,526
-534 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$129.87 - $162.82 $69,350 - $86,945
534 New
534 $287,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.